These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29402676)

  • 1. Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.
    Pauly NJ; Slavova S; Delcher C; Freeman PR; Talbert J
    Drug Alcohol Depend; 2018 Mar; 184():26-32. PubMed ID: 29402676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
    Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
    Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.
    Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M
    Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids.
    Liang D; Shi Y
    Drug Alcohol Rev; 2019 Jul; 38(5):494-502. PubMed ID: 31317593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.
    Young LD; Kreiner PW; Panas L
    Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses.
    Cerdá M; Ponicki WR; Smith N; Rivera-Aguirre A; Davis CS; Marshall BDL; Fink DS; Henry SG; Castillo-Carniglia A; Wintemute GJ; Gaidus A; Gruenewald PJ; Martins SS
    Epidemiology; 2020 Jan; 31(1):32-42. PubMed ID: 31596794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
    Hartung DM; Ahmed SM; Middleton L; Van Otterloo J; Zhang K; Keast S; Kim H; Johnston K; Deyo RA
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1053-1060. PubMed ID: 28722211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons.
    Liang D; Shi Y
    Drug Alcohol Depend; 2020 Jan; 206():107754. PubMed ID: 31786399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Implementation of Prescription Drug Monitoring Programs in the Emergency Department.
    Elder JW; DePalma G; Pines JM
    West J Emerg Med; 2018 Mar; 19(2):387-391. PubMed ID: 29560070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.
    Toce MS; Michelson KA; Hudgins JD; Hadland SE; Olson KL; Monuteaux MC; Bourgeois FT
    Ann Emerg Med; 2023 Apr; 81(4):429-437. PubMed ID: 36669914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.
    Hawk K; D'Onofrio G; Fiellin DA; Chawarski MC; O'Connor PG; Owens PH; Pantalon MV; Bernstein SL
    Acad Emerg Med; 2018 May; 25(5):508-516. PubMed ID: 29165853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.
    Moyo P; Simoni-Wastila L; Griffin BA; Harrington D; Alexander GC; Palumbo F; Onukwugha E
    Health Serv Res; 2019 Oct; 54(5):1045-1054. PubMed ID: 31372990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Literature Review of Prescription Drug Monitoring Programs.
    Ponnapalli A; Grando A; Murcko A; Wertheim P
    AMIA Annu Symp Proc; 2018; 2018():1478-1487. PubMed ID: 30815193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995-2017: A difference-in-differences analysis.
    Earlywine JJ; Hadland SE; Raifman J
    PLoS Med; 2020 Sep; 17(9):e1003272. PubMed ID: 32976539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.
    Ali MM; Dowd WN; Classen T; Mutter R; Novak SP
    Addict Behav; 2017 Jun; 69():65-77. PubMed ID: 28152391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.